UroMark—a urinary biomarker assay for the detection of bladder cancer

BACKGROUND: Bladder cancer (BC) is one of the most common cancers in the western world and ranks as the most expensive to manage, due to the need for cystoscopic examination. BC shows frequent changes in DNA methylation, and several studies have shown the potential utility of urinary biomarkers by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik, Rodney, Simon, Mehmood, Ahmed, Villacampa, Felipe, de la Rosa, Federico, Jameson, Charles, Cheng, Kar Keung, Zeegers, Maurice P., Bryan, Richard T., James, Nicholas D., Paramio, Jesus M., Freeman, Alex, Beck, Stephan, Kelly, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282868/
https://www.ncbi.nlm.nih.gov/pubmed/28163793
http://dx.doi.org/10.1186/s13148-016-0303-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282868/
https://www.ncbi.nlm.nih.gov/pubmed/28163793
http://dx.doi.org/10.1186/s13148-016-0303-5

Ejemplares similares